Drug Shortage Report for TERBINAFINE
| Report ID | 250151 |
| Drug Identification Number | 02385279 |
| Brand name | TERBINAFINE |
| Common or Proper name | TERBINAFINE |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TERBINAFINE |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | D01BA |
| ATC description | ANTIFUNGALS FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-04-29 | French | Compare |
| v5 | 2025-04-29 | English | Compare |
| v4 | 2025-04-29 | French | Compare |
| v3 | 2025-04-29 | English | Compare |
| v2 | 2025-02-11 | French | Compare |
| v1 | 2025-02-11 | English | Compare |
Showing 1 to 6 of 6